Peritoneum for Females Only
Primary Site | Histology | Sex | Staging Type |
---|---|---|---|
C481-C482, C488 | 8000-8576, 8590-8671, 8930-8934, 8940-9110 | 2, 6 | TNM 7 and Summary Stage |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C481 Specified parts of peritoneum (including omentum and mesentery) C482 Peritoneum, NOS C488 Overlapping lesion of retroperitoneum and peritoneum **Note 1:** This schema is based on the UICC chapter *Ovary,* pages 222-22. * Primary sites C481, C482 and C488 are not listed in this chapter of the UICC manual; however, they are included in this schema and TNM staged if appropriate histology criteria are met **Note 2:** TNM values correspond to the stages accepted by the Federation Internationale de Gynecologic et d'Obstetrique (FIGO). Note that FIGO uses a single stage value which corresponds to different groupings of T, N, and M values. **Note 3:** The FIGO stages are based on surgical staging. (TNM stages are based on clinical and/or pathologic classification). **Note 4:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Retroperitoneum & Peritoneum* chapter on page 188 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=188).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes | NAACCR #940 | None | |
Clinical N | <BLANK> | Yes | NAACCR #950 | None | |
Clinical M | <BLANK> | Yes | NAACCR #960 | None | |
TNM Clin Stage Group | 99 | Yes | NAACCR #970 | None | |
Pathologic T | <BLANK> | Yes | NAACCR #880 | None | |
Pathologic N | <BLANK> | Yes | NAACCR #890 | None | |
Pathologic M | <BLANK> | Yes | NAACCR #900 | None | |
TNM Path Stage Group | 99 | Yes | NAACCR #910 | None | |
SSF1: Carbohydrate Antigen 125 (CA-125) | 999 | No | NAACCR #2880 | CCCR/Canada COC SEER |
None |
SSF2: FIGO Stage | 988 | No | NAACCR #2890 | CCCR/Canada COC |
None |
SSF3: Residual Tumor Status and Size After Primary Cytoreduction Surgery | 999 | No | NAACCR #2900 | CCCR/Canada COC SEER |
None |
SSF4: Tumor Location after Primary Cytoreduction (Debulking) Surgery | 988 | No | NAACCR #2910 | None | None |
SSF5: Malignant Ascites | 988 | No | NAACCR #2920 | None | None |
Sex | 9 | Yes | NAACCR #220 | None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No | NAACCR #390 | None | |
Primary Site | <BLANK> | Yes | NAACCR #400 | None | |
Histology | <BLANK> | Yes | NAACCR #522 | None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes | NAACCR #1639 | None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes | NAACCR #1380 | None | |
Regional Nodes Positive | <BLANK> | Yes | NAACCR #820 | None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | 1.1 | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
None |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
None |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
None |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
None |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
None |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
None |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
None |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
None |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
None |
None |